Topics are usually proposed by public authorities, universities, professional associations but any citizen can also submit a research proposal.
The KCE is not involved in the political choices based on the reports it publishes. However, it may be required to intervene in implementation phases when its technical skills are an essential added value.
KCE is a type B parastatal organisation. This status guarantees total independence from the subsidiary powers, who essentially are the federal authorities (INAMI for 75% and FPS Health and Social Security, together for 25%). In addition, some specific European subsidies cover KCE’s involvement in international research networks and projects.
The KCE mission encompasses five areas of expertise:
- Organisation and financing of health care in the broadest sense – Health Services Research
- Evaluation of medical technologies – Health Technology Assessment
- The production of clinical practice guidelines and their constant adaptation to new scientific developments – Good Clinical Practice
- Setting up and coordination of the Belgian non-commercial clinical research programme – KCE Trials programme
- Creation of accurate methodological manuals to establish validated working methods for all health care and public health researchers – Methods
In 2017, KCE published 18 reports.
We want to be:
to achieve a healthcare that is
Of high quality
Our Board of Directors (hereinafter, the “Board”), consists of representatives of the public authorities and the most important actors in healthcare, health insurance and patient associations, in a balanced composition. At each Board meeting our new finalised reports are presented. The scientific content is in principle not subject to modification, except on the basis of quantifiable methodological arguments. The political recommendations, based upon the scientific work, are then discussed, sometimes nuanced, and approved by a simple majority, when voting turns out to be necessary.
Finally, KCE is legally obliged to publish all of its results within one month of their approval by the Board, which is an additional guarantee for our independency and transparency.